Literature DB >> 21477424

Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies.

R I Ehrlich1, S Adams, R Baatjies, M F Jeebhay.   

Abstract

BACKGROUND: There is renewed interest in the chronic respiratory sequelae of pulmonary tuberculosis (PTB), particularly chronic airflow limitation. A number of South African epidemiological studies have been published, which, although not specifically designed to examine this association, provide useful data on the nature of the relationship.
OBJECTIVE: To review population-based and occupational studies conducted in South Africa that provide estimates of the association between PTB, chronic symptoms and lung function loss.
RESULTS: Two general population and a number of occupational studies were included. Most were able to control for likely confounders. Chronic chest symptoms and lung function loss were consistently associated with PTB, whether measured by self-report or prospectively in cohort studies. Odds ratios (ORs) were higher for chronic bronchitis (range 1.5-7.2) than for asthma (range 0.7-2.2). For spirometrically defined chronic obstructive pulmonary disease, the OR range was 2.6-8.9, depending on definition. Combined obstructive/restrictive lung function loss was the most common functional outcome, with a net obstructive effect. The association of past TB with non-specific bronchial hyperresponsiveness was equivocal.
CONCLUSION: These studies add to the evidence of a strong association between PTB, even if treated, and subsequent airflow obstruction as well as restrictive loss. Unanswered questions include extent of recovery over time, effect modification by smoking and other cofactors, and degree of reversibility by treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21477424     DOI: 10.5588/ijtld.10.0526

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  28 in total

1.  Effectiveness of a home-based pulmonary rehabilitation programme in pulmonary function and health related quality of life for patients with pulmonary tuberculosis: a pilot study.

Authors:  Donna de Grass; Shamila Manie; Seyi Ladele Amosun
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Chronic Obstructive Pulmonary Disease Prevalence and Associated Factors in a Setting of Well-Controlled HIV, A Cross-Sectional Study.

Authors:  Alex Kayongo; Adaeze C Wosu; Tasmia Naz; Faith Nassali; Robert Kalyesubula; Bruce Kirenga; Robert A Wise; Trishul Siddharthan; William Checkley
Journal:  COPD       Date:  2020-05-28       Impact factor: 2.409

3.  Chronic respiratory disease in adults treated for tuberculosis in Khartoum, Sudan.

Authors:  R K Osman; K Mortimer; G Bjune; A I El Sony
Journal:  Public Health Action       Date:  2016-09-21

Review 4.  Assessment of treatment response in tuberculosis.

Authors:  Neesha Rockwood; Elsa du Bruyn; Thomas Morris; Robert J Wilkinson
Journal:  Expert Rev Respir Med       Date:  2016-03-31       Impact factor: 3.772

5.  Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa.

Authors:  Lukas Fenner; Stewart E Reid; Matthew P Fox; Daniela Garone; Maureen Wellington; Hans Prozesky; Marcel Zwahlen; Michael Schomaker; Gilles Wandeler; Nzali Kancheya; Andrew Boulle; Robin Wood; German Henostroza; Matthias Egger
Journal:  Trop Med Int Health       Date:  2012-11-30       Impact factor: 2.622

6.  Noncommunicable Lung Disease in Sub-Saharan Africa. A Community-based Cross-Sectional Study of Adults in Urban Malawi.

Authors:  Jamilah Meghji; Gilbert Nadeau; Kourtney J Davis; Duolao Wang; Moffat J Nyirenda; Stephen B Gordon; Kevin Mortimer
Journal:  Am J Respir Crit Care Med       Date:  2016-07-01       Impact factor: 21.405

7.  Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study.

Authors:  Emily B Wong; Stephen Olivier; Resign Gunda; Olivier Koole; Ashmika Surujdeen; Dickman Gareta; Day Munatsi; Tshwaraganang H Modise; Jaco Dreyer; Siyabonga Nxumalo; Theresa K Smit; Greg Ording-Jespersen; Innocentia B Mpofana; Khadija Khan; Zizile E L Sikhosana; Sashen Moodley; Yen-Ju Shen; Thandeka Khoza; Ngcebo Mhlongo; Sanah Bucibo; Kennedy Nyamande; Kathy J Baisley; Diego Cuadros; Frank Tanser; Alison D Grant; Kobus Herbst; Janet Seeley; Willem A Hanekom; Thumbi Ndung'u; Mark J Siedner; Deenan Pillay
Journal:  Lancet Glob Health       Date:  2021-07       Impact factor: 26.763

Review 8.  The challenge of chronic lung disease in HIV-infected children and adolescents.

Authors:  Heinrich C Weber; Robert P Gie; Mark F Cotton
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

9.  Tuberculosis-associated mortality in Shanghai, China: a longitudinal study.

Authors:  Weibing Wang; Qi Zhao; Zhengan Yuan; Yihui Zheng; Yixing Zhang; Liping Lu; Yun Hou; Yue Zhang; Biao Xu
Journal:  Bull World Health Organ       Date:  2015-09-28       Impact factor: 9.408

Review 10.  Adolescent tuberculosis.

Authors:  Kathryn J Snow; Andrea T Cruz; James A Seddon; Rashida A Ferrand; Silvia S Chiang; Jennifer A Hughes; Beate Kampmann; Steve M Graham; Peter J Dodd; Rein M Houben; Justin T Denholm; Susan M Sawyer; Katharina Kranzer
Journal:  Lancet Child Adolesc Health       Date:  2019-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.